Big Dick Energy! may be harmful due to hidden drug ingredient
[5-29-2026] The Food and Drug Administration is advising consumers not to purchase or use Big Dick Energy!, a…
Urgent new alert to anyone taking Ramipril after ‘dosage error’
A batch of the blood pressure medication is being recalled The outer carton(Image: MHRA) People taking a blood…
HIO tells doctors to switch diabetes patients to Ozempic as stocks run out
The Health Insurance Organisation (HIO) has announced that stocks of Victoza, a widely prescribed injectable diabetes medication, have…
Japan passes bill to raise co-payments for prescription drugs similar to OTC counterparts
Japan on Friday passed legislation to raise co-payments for prescription medicines with ingredients and effects similar to over-the-counter…
FDA seizes Rs 73 lakh meds for misleading claims in Maharashtra | Mumbai News
Mumbai: In a statewide crackdown on misleading drug advertisements and sale of misbranded medicines, the state Food and…
Taking Ozempic? Here’s What Experts Say You Should Be Eating
Brandon Bell Getty Images Millions of Americans are now taking Ozempic and other GLP-1 medications, and what ends…
Batch of widely prescribed blood pressure drug recalled after packaging error
It follows a complaint from a health professional who found two blister strips of 10mg tablets inside a…
Pharmacies in England to prescribe more medication from autumn – BBC
Pharmacies in England to prescribe more medication from autumn BBCNHS-funded community independent prescribing announced as part of pharmacy contract The…
Kambo: What is the frog poison ‘spiritual ritual’ killing detoxers? | Government News
A number of people around the world have died after taking part in an ancient healing practice known…
Can Ozempic Treat Alcoholism? Here’s What You Should Know
Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the…
Lilly’s Mounjaro tops other GLP-1s for some type 2 diabetes patients
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and…
Rilzabrutinib authorised to treat adults with immune thrombocytopenia when prior treatments have been insufficient
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (29 May 2026) granted a marketing authorisation for the medicines rilzabrutinib…